Y-mAbs Names Michael Rossi As President And Chief Executive Officer And Director
Portfolio Pulse from Happy Mohamed
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) has appointed Michael Rossi as its new President and CEO, effective from November 6, 2023. Rossi brings over 30 years of experience in the radiopharmaceutical industry, having held leadership roles at Advanced Accellerators Applications, Jubilant Radiopharm, GE Healthcare, and Mirion Technologies. Thomas Gad, the founder of Y-mAbs, will assume the roles of Vice Chairman of the Board of Directors and Chief Business Officer.
October 18, 2023 | 8:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Y-mAbs Therapeutics has announced a leadership change with the appointment of Michael Rossi as President and CEO. This could potentially bring new strategic directions and growth for the company.
Leadership changes can often lead to shifts in company strategy and potentially impact stock performance. Given Rossi's extensive experience in the industry, this could be seen as a positive move for Y-mAbs, potentially leading to growth and strategic advancements.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100